MIF allele-dependent regulation of the MIF coreceptor CD44 and role in rheumatoid arthritis
暂无分享,去创建一个
J. Bernhagen | L. Leng | R. Bucala | Patty J. Lee | C. Ritchlin | M. Sauler | P. Tilstam | Wan-Uk Kim | C. Cho | Xin Du | Tian Wang | S. Yoo | Aihua Liu | K. Kim | Yan Song | J. Kong | Hyung-Ju Yoon | B. Kim | Seung-Ah Yoo
[1] Weiling Fu,et al. Transcription factor ICBP90 regulates the MIF promoter and immune susceptibility locus. , 2016, The Journal of clinical investigation.
[2] S. Gaffen. IL-17 receptor composition , 2015, Nature Reviews Immunology.
[3] W. L. Jorgensen,et al. Macrophage Migration Inhibitory Factor Is Detrimental in Pneumococcal Pneumonia and a Target for Therapeutic Immunomodulation. , 2015, The Journal of infectious diseases.
[4] G. Fingerle-Rowson,et al. Macrophage migration inhibitory factor is essential for osteoclastogenic mechanisms in vitro and in vivo mouse model of arthritis. , 2015, Cytokine.
[5] R. Bucala,et al. The integral role of CD74 in antigen presentation, MIF signal transduction, and B cell survival and homeostasis. , 2014, Mini reviews in medicinal chemistry.
[6] S. Kummerfeld,et al. PILRα Negatively Regulates Mouse Inflammatory Arthritis , 2014, The Journal of Immunology.
[7] K. Sheng,et al. Macrophage migration inhibitory factor receptor CD74 mediates alphavirus-induced arthritis and myositis in murine models of alphavirus infection. , 2013, Arthritis and rheumatism.
[8] W. L. Jorgensen,et al. Limiting Cardiac Ischemic Injury by Pharmacological Augmentation of Macrophage Migration Inhibitory Factor–AMP-Activated Protein Kinase Signal Transduction , 2013, Circulation.
[9] K. Sheng,et al. MIF receptor CD74 mediates alphavirus-induced arthritis and myositis: Requirement for CD74 in Alphavirus Arthritis and Myositis , 2013 .
[10] L. Leng,et al. Macrophage-derived, macrophage migration inhibitory factor (MIF) is necessary to induce disease in the K/BxN serum-induced model of arthritis , 2013, Rheumatology International.
[11] Chun-Yin Huang,et al. Macrophage migration inhibitory factor increases cell motility and up‐regulates αvβ3 integrin in human chondrosarcoma cells , 2012, Journal of cellular biochemistry.
[12] H. Ehrlich,et al. Neutralization of Macrophage Migration Inhibitory Factor (MIF) by Fully Human Antibodies Correlates with Their Specificity for the β-Sheet Structure of MIF* , 2012, The Journal of Biological Chemistry.
[13] Ruth R. Montgomery,et al. Dual effect of the macrophage migration inhibitory factor gene on the development and severity of human systemic lupus erythematosus. , 2011, Arthritis and rheumatism.
[14] Julia L. Gregory,et al. Macrophage Migration Inhibitory Factor and CD74 Regulate Macrophage Chemotactic Responses via MAPK and Rho GTPase , 2011, The Journal of Immunology.
[15] Zhinan Yin,et al. A Small-Molecule Macrophage Migration Inhibitory Factor Antagonist Protects against Glomerulonephritis in Lupus-Prone NZB/NZW F1 and MRL/lpr Mice , 2011, The Journal of Immunology.
[16] W. L. Jorgensen,et al. Receptor agonists of macrophage migration inhibitory factor. , 2010, Bioorganic & medicinal chemistry letters.
[17] Zoe Cournia,et al. Optimization of N-benzyl-benzoxazol-2-ones as receptor antagonists of macrophage migration inhibitory factor (MIF). , 2010, Bioorganic & medicinal chemistry letters.
[18] A. Silman,et al. UvA-DARE (Digital Academic Repository) 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative Aletaha, , 2010 .
[19] A. Silman,et al. Rheumatoid arthritis classifi cation criteria : an American College of Rheumatology / European League Against Rheumatism collaborative initiative , 2010 .
[20] E. Karlson,et al. Expression of CD44 variant isoforms CD44v3 and CD44v6 is increased on T cells from patients with systemic lupus erythematosus and is correlated with disease activity. , 2010, Arthritis and rheumatism.
[21] L. Leng,et al. Autoimmune diseases: MIF as a therapeutic target , 2010, Expert opinion on therapeutic targets.
[22] P. Robbins,et al. Synovial fibroblasts spread rheumatoid arthritis to unaffected joints , 2009, Nature Medicine.
[23] J. Bernhagen,et al. A functional heteromeric MIF receptor formed by CD74 and CXCR4 , 2009, FEBS letters.
[24] J. Bernhagen,et al. The Golgi-Associated Protein p115 Mediates the Secretion of Macrophage Migration Inhibitory Factor1 , 2009, The Journal of Immunology.
[25] T. Ludwig,et al. CD44 Variant Isoforms Promote Metastasis Formation by a Tumor Cell-Matrix Cross-talk That Supports Adhesion and Apoptosis Resistance , 2009, Molecular Cancer Research.
[26] J. Byrd,et al. Combination anti-CD74 (milatuzumab) and anti-CD20 (rituximab) monoclonal antibody therapy has in vitro and in vivo activity in mantle cell lymphoma. , 2008, Blood.
[27] J. Bernhagen,et al. Interactions of T helper cells with fibroblast-like synoviocytes: up-regulation of matrix metalloproteinases by macrophage migration inhibitory factor from both Th1 and Th2 cells. , 2008, Arthritis and rheumatism.
[28] R. Weinberg,et al. Growth-Inhibitory and Tumor- Suppressive Functions of p53 Depend on Its Repression of CD44 Expression , 2008, Cell.
[29] C. Metz,et al. Macrophage migration inhibitory factor up-regulates alpha(v)beta(3) integrin and vascular endothelial growth factor expression in endometrial adenocarcinoma cell line Ishikawa. , 2008, Journal of reproductive immunology.
[30] L. Leng,et al. Macrophage Migration Inhibitory Factor Induces B Cell Survival by Activation of a CD74-CD44 Receptor Complex* , 2008, Journal of Biological Chemistry.
[31] D. Stepensky,et al. FRETcalc plugin for calculation of FRET in non-continuous intracellular compartments. , 2007, Biochemical and biophysical research communications.
[32] A. Koch. The pathogenesis of rheumatoid arthritis. , 2007, American journal of orthopedics.
[33] Georg Schett,et al. Cytokines in the pathogenesis of rheumatoid arthritis , 2007, Nature Reviews Immunology.
[34] L. Bourguignon,et al. Association of CD44 V3‐containing isoforms with tumor cell growth, migration, matrix metalloproteinase expression, and lymph node metastasis in head and neck cancer , 2007, Head & neck.
[35] Wan-Uk Kim,et al. Soluble Fas ligand inhibits angiogenesis in rheumatoid arthritis , 2007, Arthritis research & therapy.
[36] K. Tung,et al. Phosphorylated ERM Is Responsible for Increased T Cell Polarization, Adhesion, and Migration in Patients with Systemic Lupus Erythematosus12 , 2007, The Journal of Immunology.
[37] L. Leng,et al. CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex. , 2006, Immunity.
[38] S. Stamm,et al. Splicing factor Tra2-beta1 is specifically induced in breast cancer and regulates alternative splicing of the CD44 gene. , 2006, Cancer research.
[39] J. Bernhagen,et al. MIF: a new cytokine link between rheumatoid arthritis and atherosclerosis , 2006, Nature Reviews Drug Discovery.
[40] A. Maitra,et al. Cutting Edge: Evidence for Ligand-Independent Multimerization of the IL-17 Receptor1 , 2006, The Journal of Immunology.
[41] T. Calandra,et al. Macrophage migration inhibitory factor: gene polymorphisms and susceptibility to inflammatory diseases. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[42] G. Prestwich,et al. Regulation of lung injury and repair by Toll-like receptors and hyaluronan , 2005, Nature Medicine.
[43] B. Franke,et al. Correlation of rheumatoid arthritis severity with the genetic functional variants and circulating levels of macrophage migration inhibitory factor. , 2005, Arthritis and rheumatism.
[44] M. Symons,et al. Rho GTPase-dependent Signaling Is Required for Macrophage Migration Inhibitory Factor-mediated Expression of Cyclin D1* , 2005, Journal of Biological Chemistry.
[45] E. Zeggini,et al. A functional promoter haplotype of macrophage migration inhibitory factor is linked and associated with juvenile idiopathic arthritis. , 2004, Arthritis and rheumatism.
[46] O. Petrenko,et al. The p53-dependent effects of macrophage migration inhibitory factor revealed by gene targeting , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[47] R. Bucala,et al. Regulation of p53 by macrophage migration inhibitory factor in inflammatory arthritis. , 2003, Arthritis and rheumatism.
[48] L. Leng,et al. MIF Signal Transduction Initiated by Binding to CD74 , 2003, The Journal of experimental medicine.
[49] R. Bucala,et al. Adhesion-dependent Signaling by Macrophage Migration Inhibitory Factor (MIF)* , 2003, The Journal of Biological Chemistry.
[50] E. Génot,et al. Influence of epitopes CD44v3 and CD44v6 in the invasive behavior of fibroblast-like synoviocytes derived from rheumatoid arthritic joints. , 2002, Arthritis and rheumatism.
[51] R. Bucala,et al. Macrophage migration inhibitory factor in rheumatoid arthritis: clinical correlations. , 2002, Rheumatology.
[52] P. Gregersen,et al. A functional promoter polymorphism in the macrophage migration inhibitory factor (MIF) gene associated with disease severity in rheumatoid arthritis , 2002, Genes and Immunity.
[53] Lilly Y. W. Bourguignon,et al. Signaling Properties of Hyaluronan Receptors* , 2002, The Journal of Biological Chemistry.
[54] E. Morand,et al. Regulation of synoviocyte phospholipase A2 and cyclooxygenase 2 by macrophage migration inhibitory factor. , 2001, Arthritis and rheumatism.
[55] R. Gay,et al. Anti-interleukin-1 and anti-CD44 interventions producing significant inhibition of cartilage destruction in an in vitro model of cartilage invasion by rheumatoid arthritis synovial fibroblasts. , 2000, Arthritis and rheumatism.
[56] R. Bucala,et al. Regulation of macrophage migration inhibitory factor by endogenous glucocorticoids in rat adjuvant-induced arthritis. , 2000, Arthritis and rheumatism.
[57] R. Bucala,et al. Macrophage migration inhibitory factor in rheumatoid arthritis: evidence of proinflammatory function and regulation by glucocorticoids. , 1999, Arthritis and rheumatism.
[58] Tina Peng,et al. Sustained Mitogen-activated Protein Kinase (MAPK) and Cytoplasmic Phospholipase A2 Activation by Macrophage Migration Inhibitory Factor (MIF) , 1999, The Journal of Biological Chemistry.
[59] D. Green,et al. Somatic mutations in the p53 tumor suppressor gene in rheumatoid arthritis synovium. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[60] L. Pirilä,et al. H-ras oncogene point mutations in arthritic synovium. , 1997, Arthritis and rheumatism.
[61] H. Diamond,et al. Interleukin-1beta-stimulated invasion of articular cartilage by rheumatoid synovial fibroblasts is inhibited by antibodies to specific integrin receptors and by collagenase inhibitors. , 1997, Arthritis and rheumatism.
[62] R. Holmdahl,et al. Macrophage migration inhibitory factor is involved in the pathogenesis of collagen type II-induced arthritis in mice. , 1997, Journal of immunology.
[63] R. Bucala,et al. Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome , 1997, Nature Medicine.
[64] T. Glant,et al. Anti-CD44 treatment abrogates tissue aedema and leukocyte infiltration in murine arthrtis , 1995, Nature Medicine.
[65] J. Bernhagen,et al. Purification, bioactivity, and secondary structure analysis of mouse and human macrophage migration inhibitory factor (MIF). , 1994, Biochemistry.
[66] Mark S. Anderson,et al. The chondroitin sulfate form of invariant chain can enhance stimulation of T cell responses through interaction with CD44 , 1993, Cell.
[67] R. Bucala,et al. Constitutive production of inflammatory and mitogenic cytokines by rheumatoid synovial fibroblasts , 1991, The Journal of experimental medicine.
[68] N. Bottini,et al. Duality of fibroblast-like synoviocytes in RA: passive responders and imprinted aggressors , 2013, Nature Reviews Rheumatology.
[69] J. Smolen,et al. Expression patterns of CD44 and CD44 splice variants in patients with rheumatoid arthritis. , 2012, Clinical and experimental rheumatology.
[70] R. Bucala. MIF, MIF Alleles, and Prospects for Therapeutic Intervention in Autoimmunity , 2012, Journal of Clinical Immunology.
[71] Peter Zenz,et al. The rationale of pharmacoeconomic analysis in rheumatologic indications. , 2012 .
[72] P. Herrlich,et al. CD44: From adhesion molecules to signalling regulators , 2003, Nature Reviews Molecular Cell Biology.
[73] R. Bucala,et al. Control of fibroblast-like synoviocyte proliferation by macrophage migration inhibitory factor. , 2003, Arthritis and rheumatism.
[74] J. Sleeman,et al. CD44 variants but not CD44s cooperate with beta1-containing integrins to permit cells to bind to osteopontin independently of arginine-glycine-aspartic acid, thereby stimulating cell motility and chemotaxis. , 1999, Cancer research.
[75] G. Firestein. Somatic mutation in the tumore suppressor gene in erosive rheumatoid arthritis synovium , 1997 .